OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effectiveness and safety of secukinumab in Chinese patients with moderate to severe plaque psoriasis in real‐world practice
Jian Zhou, Yuan Yuan, Yanhua Liu, et al.
Experimental Dermatology (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 8
Jian Zhou, Yuan Yuan, Yanhua Liu, et al.
Experimental Dermatology (2023) Vol. 33, Iss. 1
Open Access | Times Cited: 8
Showing 8 citing articles:
Insulin resistance impairs biologic agent response in moderate-to-severe plaque psoriasis: insights from a prospective cohort study in China
Dawei Huang, Xiaoyuan Zhong, Yuxiong Jiang, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 616-623
Closed Access | Times Cited: 9
Dawei Huang, Xiaoyuan Zhong, Yuxiong Jiang, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 4, pp. 616-623
Closed Access | Times Cited: 9
Successful treatment of generalized pustular psoriasis during pregnancy with secukinumab in a patient hypersensitive to spesolimab: a case report
Shuang Zhang, Gang‐Ding Peng, Yun Zhang, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Shuang Zhang, Gang‐Ding Peng, Yun Zhang, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access
Childhood guttate psoriasis: an updated review
Alexander K. C. Leung, Benjamin Barankin, Joseph M. Lam, et al.
Drugs in Context (2023) Vol. 12, pp. 1-20
Open Access | Times Cited: 10
Alexander K. C. Leung, Benjamin Barankin, Joseph M. Lam, et al.
Drugs in Context (2023) Vol. 12, pp. 1-20
Open Access | Times Cited: 10
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study
Marco Galluzzo, Emanuele Trovato, Mark S. Talamonti, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3864-3864
Open Access | Times Cited: 1
Marco Galluzzo, Emanuele Trovato, Mark S. Talamonti, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3864-3864
Open Access | Times Cited: 1
Predictors for the effectiveness of 75 mg risankizumab in treating psoriasis—A real‐word evidence from a 52‐week retrospective study
Chang‐Yu Hsieh, Yu‐Hsian Tseng, Tsen‐Fang Tsai
Experimental Dermatology (2023) Vol. 32, Iss. 12, pp. 2138-2148
Open Access | Times Cited: 3
Chang‐Yu Hsieh, Yu‐Hsian Tseng, Tsen‐Fang Tsai
Experimental Dermatology (2023) Vol. 32, Iss. 12, pp. 2138-2148
Open Access | Times Cited: 3
Clinical characteristics and outcomes of psoriasis patients with COVID-19: A retrospective, multicenter cohort study in China
Yanhua Liu, Zhongrui Xu, Jian Zhou, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 14, pp. 1736-1743
Open Access
Yanhua Liu, Zhongrui Xu, Jian Zhou, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 14, pp. 1736-1743
Open Access
Reflectance confocal microscopy for plaque psoriasis therapeutic follow-up during an anti-interleukin-17A monoclonal antibody: an observational study
Qian Jiang, Zilu Qu, Bei Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Qian Jiang, Zilu Qu, Bei Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Relationships between Secukinumab Concentrations, Disease Activity, and Il-17a Levels in Psoriasis: A Cross-Sectional Observational Study
K. Zhu, Lu Zhou, Lei Cao, et al.
(2024)
Closed Access
K. Zhu, Lu Zhou, Lei Cao, et al.
(2024)
Closed Access
